Biocon News: Read Latest News & Live Updates on Biocon, Photos, Videos at CNBCTV18.com

homeBiocon News

Biocon NEWS

All

market | May 13, 2024 12:14 PM IST
Biocon inks distribution, supply deal for obesity treatment drug in Mexico
business | Apr 17, 2024 9:12 PM IST
Biocon partners Biomm to commercialise diabetes drug in Brazil
market | Mar 28, 2024 8:01 AM IST
Biocon becomes the first generics company to get a diabetes drug approval in the UK
business | Mar 15, 2024 5:48 PM IST
Biocon Biologics CEO terms Eris Lifesciences deal as enabling, not restricting
market | Mar 14, 2024 3:19 PM IST
Biocon Biologics signs 10-year supply pact with Eris Life for ₹1,242 crore
healthcare | Mar 4, 2024 9:46 AM IST
Biocon Biologics gets Canada market entry date for ophthalmic drug Yesafili
business | Feb 23, 2024 5:18 PM IST
Biocon gets over ₹3 crore penalty over GST related issues
market | Feb 9, 2024 10:31 AM IST
Biocon arm gets complete response letter from USFDA for Bevacizumab biosimilar licence application
photos | Feb 9, 2024 12:09 AM IST
Stocks to Watch: LIC, Hero Motocorp, Biocon, Grasim Industries, Torrent Power, RVNL and more
earnings | Feb 8, 2024 8:53 PM IST
Biocon bounces back to black, reports ₹660 crore net profit, revenue up 34%
earnings | Jan 25, 2024 3:35 PM IST
Syngene Q3 results: Biocon unit cuts FY24 revenue growth guidance
healthcare | Dec 22, 2023 5:36 PM IST
Biocon Biologics, Sandoz ink deal to market immune disorder injection adalimumab in Japan
business | Dec 19, 2023 9:23 AM IST
Biocon chief sees generics business firing up next year
healthcare | Dec 18, 2023 5:07 PM IST
Biocon Biologics takes charge of Viatris' biosimilars across 120 countries
photos | Dec 14, 2023 7:08 AM IST
Stocks to Watch: SBI, Biocon, JSW Energy, UltraTech Cement, IndiGo, Fusion Micro Finance and more

Biocon NEWS

Biocon inks distribution, supply deal for obesity treatment drug in Mexico

Biocon partners Biomm to commercialise diabetes drug in Brazil

Biocon becomes the first generics company to get a diabetes drug approval in the UK

Biocon Biologics CEO terms Eris Lifesciences deal as enabling, not restricting

Biocon Biologics signs 10-year supply pact with Eris Life for ₹1,242 crore

Biocon Biologics gets Canada market entry date for ophthalmic drug Yesafili

Biocon gets over ₹3 crore penalty over GST related issues

Biocon arm gets complete response letter from USFDA for Bevacizumab biosimilar licence application

Stocks to Watch: LIC, Hero Motocorp, Biocon, Grasim Industries, Torrent Power, RVNL and more

Biocon bounces back to black, reports ₹660 crore net profit, revenue up 34%

Syngene Q3 results: Biocon unit cuts FY24 revenue growth guidance

Biocon Biologics, Sandoz ink deal to market immune disorder injection adalimumab in Japan

Biocon chief sees generics business firing up next year

Biocon Biologics takes charge of Viatris' biosimilars across 120 countries

Stocks to Watch: SBI, Biocon, JSW Energy, UltraTech Cement, IndiGo, Fusion Micro Finance and more